411
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Type I interferon therapy and its role in autoimmunity

, &
Pages 248-254 | Received 25 Nov 2009, Accepted 25 Nov 2009, Published online: 19 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

You Li, Jihong Dai, Mangen Song, Patricia Fitzgerald-Bocarsly & Megerditch Kiledjian. (2012) Dcp2 Decapping Protein Modulates mRNA Stability of the Critical Interferon Regulatory Factor (IRF) IRF-7. Molecular and Cellular Biology 32:6, pages 1164-1172.
Read now

Articles from other publishers (21)

Li Liu, Shuangshuang Xie, Cheng Li, Yue Guo, Xiaoyan Liu, Xiuhua Zhao, Qiang Li & Wenjun Du. (2022) IFI16 induces inflammation in hepatitis B virus-associated glomerulonephritis by regulating the Caspase-1/ IL-1 ß pathway. Diagnostic Pathology 17:1.
Crossref
Qingcong Zheng, Du Wang, Rongjie Lin, Qi Lv & Wanming Wang. (2022) IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Frontiers in Immunology 13.
Crossref
Camila Metz-Zumaran, Carmon Kee, Patricio Doldan, Cuncai Guo, Megan L. Stanifer & Steeve Boulant. (2022) Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells. Journal of Virology 96:7.
Crossref
Robert H. Jenkins, Stuart T.O. Hughes, Ana Cardus Figueras & Simon A. Jones. (2021) Unravelling the broader complexity of IL-6 involvement in health and disease. Cytokine 148, pages 155684.
Crossref
Dapei Li, Rongsheng Wu, Wen Guo, Lifen Xie, Zigang Qiao, Shengchuan Chen, Jingfei Zhu, Chaohao Huang, Jian Huang, Bicheng Chen, Yanghua Qin, Feng Xu & Feng Ma. (2019) STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. Cell Reports 29:5, pages 1249-1260.e4.
Crossref
Eirini I. Rigopoulou, Sofia Gyftaki, Pinelopi Arvaniti, Vana Tsimourtou, George K. Koukoulis, Georgios Hadjigeorgiou & George N. Dalekos. (2019) Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment. Clinics and Research in Hepatology and Gastroenterology 43:3, pages e25-e32.
Crossref
Marco Cattalini, Jessica Galli, Laura Andreoli, Ivana Olivieri, Giada Ariaudo, Micaela Fredi, Simona Orcesi, Angela Tincani & Elisa Fazzi. (2016) Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome. Journal of Clinical Immunology 36:7, pages 693-699.
Crossref
Kathleen C. F. Sheehan, Helen M. Lazear, Michael S. Diamond & Robert D. Schreiber. (2015) Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection. PLOS ONE 10:5, pages e0128636.
Crossref
Javier Rodríguez-Carrio, Patricia López & Ana Suárez. (2014) Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine. Clinical Science 128:8, pages 449-464.
Crossref
Worawit Louthrenoo. (2015) Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases. Best Practice & Research Clinical Rheumatology 29:2, pages 319-342.
Crossref
Edson R.A. de Oliveira, Bruna M.M.P. Lima, Wlamir C. de Moura & Ana Cristina M. de A. Nogueira. (2013) Reduction of cell viability induced by IFN-alpha generates impaired data on antiviral assay using Hep-2C cells. Journal of Immunological Methods 400-401, pages 97-105.
Crossref
Vijay Rao & Simon Bowman. (2013) Latest advances in connective tissue disorders. Therapeutic Advances in Musculoskeletal Disease 5:4, pages 234-249.
Crossref
Ernst Peterhans & Matthias Schweizer. (2013) BVDV: A pestivirus inducing tolerance of the innate immune response. Biologicals 41:1, pages 39-51.
Crossref
Michael J. Holtzman. (2012) Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. Journal of Clinical Investigation 122:8, pages 2741-2748.
Crossref
Andreas P. Diamantopoulos, Helene Hetland, Atle E. Hansen & Geirmund Myklebust. (2011) Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1α for concomitant longstanding multiple sclerosis. Modern Rheumatology 22:3, pages 474-478.
Crossref
Daniel Salamon, Monika Adori, Minghui He, Peter Bönelt, Eva Severinson, Lorand L. Kis, Liang Wu, Dorina Ujvari, Benjamin Leveau, Noemi Nagy, George Klein & Eva Klein. (2012) Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt’s lymphoma. Cytokine 57:3, pages 360-371.
Crossref
Aisling O'Hara Hall, Jonathan S. Silver & Christopher A. Hunter. 2012. Advances in Immunology Volume 115. Advances in Immunology Volume 115 1 44 .
Sokratis A. ApostolidisLinda A. LiebermanKatalin Kis-TothJosé C. CrispínGeorge C. Tsokos. (2011) The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus. Journal of Interferon & Cytokine Research 31:10, pages 769-779.
Crossref
Michael J Holtzman, Dhara A Patel, Yong Zhang & Anand C Patel. (2011) Host epithelial–viral interactions as cause and cure for asthma. Current Opinion in Immunology 23:4, pages 487-494.
Crossref
Michael Holtzman, Dhara Patel, Hyun Kim, Yingjian You & Yong Zhang. (2011) Hypersusceptibility to Respiratory Viruses as a Shared Mechanism for Asthma, Chronic Obstructive Pulmonary Disease, and Cystic Fibrosis. American Journal of Respiratory Cell and Molecular Biology 44:6, pages 739-742.
Crossref
Giorgio Trinchieri. (2010) Type I interferon: friend or foe?. Journal of Experimental Medicine 207:10, pages 2053-2063.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.